CoChat

p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma

Doyle, Brendan, Morton, Jennifer P, Delaney, David W, Ridgway, Rachel A, Wilkins, Julie A, Sansom, Owen J · 2010 · The Journal of Pathology
Cited by 87

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Pleomorphic rhabdomyosarcoma is the most common variant of this tumour in adults and has a very poor outcome. Two genes which are known to play a role in rhabdomyosarcoma development are KRas and p53. In the majority of human tumours, p53 abnormalities are point mutations that result in the expression of a mutant form of the protein. It is now hypothesized that these mutant forms of p53 may be playing an oncogenic role, over and above simple loss of the wild‐type function. In this study, we use Cre‐LoxP technology to develop a novel mouse model of rhabdomyosarcoma, crossing mice expressing a common KRas mutation (G12V) with mice that either lose p53 expression or express a mutant form of p53. We use this model to explore the different effects of p53 loss and mutation in the setting of an activating KRas mutation. We found that either complete loss of p53 (p53$^{\rm{fl/fl}}$) or the expression of one mutant p53 allele with concomitant loss of the second allele (p53$^{\rm{R172H/fl}}$) resulted in the rapid development of rhabdomyosarcoma in 15/16 and 19/19 mice, respectively. In contrast, there was a marked difference between mice which lose a single copy of p53 (p53$^{{\rm{fl}}/+}$) and mice expressing a single copy of mutant p53 (p53$^{{\rm {172H}}/+}$). Fourteen out of 16 p53$^{{\rm{R172H}}/+}$ mice developed rhabdomyosarcoma, compared with two out of 31 p53$^{{\rm{fl}}/+}$ mice. As a consequence of this, p53$^{{\rm{fl}}/+}$ mice had a median lifespan nearly double that of the p53$^{{\rm{R172H}}/+}$ mice. To underline the enhanced effect of p53 mutation in tumour progression, metastases were seen only in those mice which expressed the mutant form. These data demonstrate that mutant p53 can co‐operate with activated, mutant KRas to influence tumourigenesis and metastatic potential, over and above simple loss of normal protein function. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/path.2748

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 87

Metadata

Authors
Doyle, B., Morton, J. P., Delaney, D. W., Ridgway, R. A., Wilkins, J. A., & Sansom, O. J.
Venue
The Journal of Pathology
Publisher
Wiley
Published
2010-09
Volume
222
Issue
2
Pages
129-137
ISSN
  • 0022-3417 (ISSN-L)
  • 1096-9896
OpenAlex
W2027853345
Cited by
87
References
9
FWCI
2.85
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma. https://app.cochat.ai/papers/10.1002/path.2748
The paper
Doyle, B., Morton, J. P., Delaney, D. W., Ridgway, R. A., Wilkins, J. A., & Sansom, O. J. (2010). p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma. The Journal of Pathology. https://doi.org/10.1002/path.2748

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.